Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01481740 · ClinicalTrials.gov registry record · Phase 4
Preventing Hypotension in Parturients With an Elevated Body Mass Index (BMI)
A Phase 4 study, sponsored by IWK Health Centre.
- Completed
- Registry status
- Phase 4
- Development phase
- 178
- Enrollment target
NCT01481740 is a Phase 4 study that has completed, run by IWK Health Centre. The registered enrollment target is 178 participants.
The verdict
NCT01481740, a Phase 4 study, has completed, sponsored by IWK Health Centre.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 178 participants
- Enrollment target
Study Summary
Previous research regarding the use of phenylephrine has excluded obese subjects (BMI \>35). This subgroup of patients represents a large portion of the obstetric patient population locally and nationally. It is unclear whether previous research should be extrapolated to the obese patient population. This study is being done to compare the incidence of hypotension, intraoperative nausea and vomiting, and neonatal acidosis between obese patients who receive a prophylactic phenylephrine infusion versus those who receive phenylephrine boluses for the treatment of established hypotension. This study will help us determine whether using a phenylephrine infusion or a phenylephrine bolus is the best way to prevent/treat spinal induced hypotension during cesarean deliveries in obese patients.
Interventions
- DRUG Phenylephrine bolus
- DRUG phenylephrine infusion
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 178 participants |
| Start Date | 2010-11 |
| Est. Completion | 2014-12 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01481740
The ClinicalTrials.gov registry entry for NCT01481740 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 178 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is IWK Health Centre, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Phenylephrine bolus is the first listed.
NCT01481740 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01481740 about?
NCT01481740 is a clinical study titled "Preventing Hypotension in Parturients With an Elevated Body Mass Index (BMI)". Previous research regarding the use of phenylephrine has excluded obese subjects (BMI \>35). This subgroup of patients represents a large portion of the obstetric patient population locally and nationally. It is unclear whether previous research should be extrapolated to the obese patient population...
What is the current status of trial NCT01481740?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 178 participants. The study started on 2010-11. Estimated completion is 2014-12.
What interventions are being tested in trial NCT01481740?
The interventions under investigation include: Phenylephrine bolus (DRUG), phenylephrine infusion (DRUG).
Who is sponsoring clinical trial NCT01481740?
This trial is sponsored by IWK Health Centre, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.